摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-Methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carbohydrazide | 775573-28-9

中文名称
——
中文别名
——
英文名称
3-Methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carbohydrazide
英文别名
——
3-Methyl-4-oxoimidazo[5,1-d][1,2,3,5]tetrazine-8-carbohydrazide化学式
CAS
775573-28-9
化学式
C6H7N7O2
mdl
——
分子量
209.17
InChiKey
OUVDREHSXNEDPW-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    -1.4
  • 重原子数:
    15
  • 可旋转键数:
    1
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.17
  • 拓扑面积:
    118
  • 氢给体数:
    2
  • 氢受体数:
    6

文献信息

  • DRUG DELIVERY OF TEMOZOLOMIDE FOR SYSTEMIC BASED TREATMENT OF CANCER
    申请人:Patil Rameshwar
    公开号:US20140161762A1
    公开(公告)日:2014-06-12
    The present invention relates to methods of drug delivery for the treatment of a condition or disease, such as cancer. In one embodiment, the invention provides a method of preparing a multifunctional nanoconjugate of temozolomide (TMZ) by conjugating TMZ in its hydrazide form to a polymalic acid platform. In another embodiment, the polymalic acid platform is conjugated to a monoclonal antibody to transferrin receptor, a trileucine (LLL) moiety, and/or a polyethylene glycol (PEG) moiety. The present invention relates to methods of drug delivery for the treatment of a condition or disease, such as cancer. In one embodiment, the invention provides a method of preparing a multifunctional nanoconjugate of temozolomide (TMZ) by conjugating TMZ in its hydrazide form to a polymalic acid platform. In another embodiment, the polymalic acid platform is conjugated to a monoclonal antibody to transferrin receptor, a trileucine (LLL) moiety, and/or a polyethylene glycol (PEG) moiety.
  • US8785371B2
    申请人:——
    公开号:US8785371B2
    公开(公告)日:2014-07-22
  • US9320807B2
    申请人:——
    公开号:US9320807B2
    公开(公告)日:2016-04-26
  • US9629919B2
    申请人:——
    公开号:US9629919B2
    公开(公告)日:2017-04-25
  • US9827325B2
    申请人:——
    公开号:US9827325B2
    公开(公告)日:2017-11-28
查看更多

同类化合物

米托唑胺 氰基替莫唑胺 替莫唑胺 N-[4-(2-氟苯甲酰)-1,3-二甲基-1H-吡唑-5-基]-N-甲基苯酰胺 3-(2H3)甲基-4-氧代-3,4-二氢咪唑并[5,1-d][1,2,3,5]四嗪-8-甲酰胺 3-(2-氯乙基)-N-甲基-4-氧代-3,4-二氢咪唑并[5,1-d][1,2,3,5]四嗪-8-甲酰胺 3-(2-氯乙基)-N,N-二甲基-4-氧代-3,4-二氢咪唑并[5,1-d][1,2,3,5]四嗪-8-甲酰胺 3-(2-氯乙基)-4-氧代-3H-咪唑并(5,1-d)-1,2,3,5-四嗪-8-羧酸 3,4-二氢-3-甲基-4-氧代咪唑并[5,1-D]-1,2,3,5-四嗪-8-甲酰胺酸 8-carbamoyl-3-(2,3-dichloropropyl)-[3H]-imidazo[5,1-d]-1,2,3,5-tetrazin-4-one 3-(2-bromoethyl)-8-carbamoyl-[3H]-imidazo[5,1-d]-1,2,3,5-tetrazin-4-one 3-(2-((4-fluoro-2-nitrophenyl)(methyl)amino)ethyl)-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-carboxamide 3-(prop-2-ynyl)-8-(4-(thiophen-3-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 8-(2,4'-bithiazol-2'-yl)-3-methylimidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(methylsulfinylmethyl)-8-(4-(thiophen-3-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(methoxymethyl)-8-(4-(thiophen-2-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one N,6-dimethyl-4-oxo-3-(2,2,2-trifluoroethyl)-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide 3-(methylthiomethyl)-8-(4-(thiophen-3-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(methylsulfinylmethyl)-8-(4-(thiophen-2-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 8-[4-(1,3-Benzodioxol-5-yl)-1,3-thiazol-2-yl]-3-(methoxymethyl)imidazo[5,1-d][1,2,3,5]tetrazin-4-one N-tert-butyl-2-(3-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazin-8-yl)thiazole-4-carboxamide 3-methyl-8-(4-(thiophen-3-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-methyl-8-(4-(thiophen-2-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(methoxymethyl)-8-(4-(thiophen-3-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(methoxymethyl)-8-(4-phenylthiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 8-(4-tert-butylthiazol-2-yl)-3-propargylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one 3-(methylthiomethyl)-8-(4-(thiophen-2-yl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 8-(4-(4-bromophenyl)thiazol-2-yl)-3-(prop-2-ynyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(methylthiomethyl)-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide 8-(morpholinosulfonyl)-3-(2,2,2-trifluoroethyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 6-methyl-8-(methylsulfonyl)-3-(prop-2-ynyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-methyl-8-(4-phenylthiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 8-(4-ethylthiazol-2-yl)-3-methylimidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 4-oxo-3-(prop-2-ynyl)-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide 8-(methylsulfonyl)-3-(prop-2-ynyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-((methoxymethylthio)methyl)-N-methyl-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide 8-[4-(4-methylsulfonylphenyl)thiazol-2-yl]-3-propargylimidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one N-methyl-4-oxo-3-(2,2,2-trifluoroethyl)-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide 8-(1-methyl-4-(thiophen-2-yl)-1H-imidazol-2-yl)-3-(prop-2-ynyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-methyl-N-(iso-butyl)-4-oxoimidazo[5,1-d]-1,2,3,5-tetrazine-8-carboxamide N,N-dimethyl-4-oxo-3-(2,2,2-trifluoroethyl)-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide 3-(methoxymethyl)-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide 8-(4-tert-butylthiazol-2-yl)-3-(methoxymethyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 8-(morpholinosulfonyl)-3-(prop-2-ynyl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-(methoxymethyl)-8-(4-(4-(methylsulfonyl)phenyl)thiazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one 3-methyl-8-(1-methyl-1H-benzo[d]imidazol-2-yl)imidazo[5,1-d][1,2,3,5]tetrazin-4(3H)-one N,6-dimethyl-3-(methylsulfinylmethyl)-4-oxo-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide N-methyl-4-oxo-3-((2,2,2-trifluoroethoxy)methyl)-3,4-dihydroimidazo[5,1-d][1,2,3,5]tetrazine-8-sulfonamide